Unequal Arterial Stiffness With Overall and Cardiovascular Mortality in Patients Receiving Hemodialysis

• Published in: The American journal of the medical sciences 2016-02, Vol.351 (2), p.187-193
• Main Authors: Wei, Shu-Yi, MD, Huang, Jiun-Chi, MD, Chen, Szu-Chia, MD, Chang, Jer-Ming, MD, PhD, Chen, Hung-Chun, MD, PhD
• Format: Article
• Language: English
• Subjects: Adult; Aged; Ankle Brachial Index; Blood Flow Velocity; Brachial-ankle pulse wave velocity difference; Cardiovascular Diseases - mortality; Female; Hemodialysis; Humans; Internal Medicine; Male; Middle Aged; Overall and cardiovascular mortality; Pulse Wave Analysis; Renal Dialysis - statistics & numerical data; Taiwan - epidemiology; Vascular Stiffness
• ISSN: 0002-9629; 1538-2990
• DOI: 10.1016/j.amjms.2015.11.017

Abstract Background Pulse wave velocity is a marker of arterial stiffness. Unequal arterial stiffness has been associated with increased risk of cardiovascular events. This study calculated bilateral brachial-ankle pulse wave velocity (baPWV) differences and investigated the associations of unequal bilateral baPWV with overall and cardiovascular mortality in patients receiving hemodialysis (HD). Materials and Methods A total of 205 patients receiving HD were enrolled in this study. The mean follow-up period was 4.4 ± 1.5 years. The baPWV was measured using an ankle-brachial index-form device, and bilateral baPWV difference was calculated and defined as ΔbaPWV. Results The median value of ΔbaPWV was 88 cm/second. ankle-brachial index < 0.95 and high baPWV were independently associated with a ΔbaPWV ≥ 88 cm/s. Furthermore, patients with a ΔbaPWV ≥ 88 cm/s demonstrated poorer overall (log-rank P = 0.035) and cardiovascular (log-rank P = 0.036) survival than did those with a ΔbaPWV < 88 cm/s. After multivariate analysis, this difference was independently associated with overall (hazard ratio = 1.006; 95% CI: 1.001-1.011; P = 0.024) and cardiovascular (hazard ratio = 1.006; 95% CI: 1.000-1.013; P = 0.049) mortality. Conclusions ΔbaPWV was associated with an increased risk of cardiovascular and overall mortality in patients receiving HD. Earlier evaluation of ΔbaPWV may facilitate the identification of patients receiving HD who have an increased risk of cardiovascular and overall mortality.